Animal Intestinal Health Market by Additive (Probiotics, Prebiotics, Phytogenics, Immunostimulants), Livestock (Poultry, Swine, Ruminant, Aquaculture), Form (Dry, Liquid), Source, Region - Global Forecast to 2027
The animal intestinal health market, estimated at USD 3.7 billion in 2022 and is projected to grow to USD 5.4 billion in 2027, at a CAGR of 8.2% from 2022 to 2027. Feed additives provide nutritional value to the regular meal consumed by animals. With the increase in population, animal intestinal feed products have also witnessed a surge in demand. To cater to the growing demand for feed products, manufacturers are focusing on utilizing probiotics, prebiotics, phytogenic feed additives, and other feed additives to enhance the gut health and productivity of livestock. The rise in awareness about meat and dairy products, health concerns related to livestock, and the increase in the industrialization of animal-processed products are the major factors driving the growth of the animal intestinal health market globally. With the imposition of regulations by government agencies on the use of antibiotics, the demand for natural feed additives to improve the quality of intestinal health products is expected to remain high.
“Europe is the second fastest growing region, projected to witness the growth of 7.62% during the forecast period in terms of volume.”
The European feed industry is one of the largest markets for feed production at a global level. European feed producers are using various feed additives based on probiotics, prebiotics, phytogenics, and immunostimulants to cater to the increase in demand for high-quality feed products for enhanced performance of livestock. Various feed producers in the region are witnessing a shift in their focus on the inclusion of prebiotics, such as mannan oligosaccharides and fructooligosaccharides, which improves performance in livestock. The European feed producers prefer using phytogenics, such as essential oils, as an alternative to feed-grade antibiotics used in pork feed production. These phytogenics act as a key feed additive, help increase feed intake and improve gut functions in the livestock.
“The microbial segment accounted for a larger market share during the forecast period”
The microbial segment accounted for a larger market share during the forecast period due to the increase in the availability of feed additives manufactured by using microorganisms. Probiotics help in weight gain, improve the digestibility of feed products, and enhance the overall gut microflora in livestock species, such as swine, ruminants, and poultry. However, with the increase in awareness about the various alternatives to microbial sources, plant-based sources of intestinal health, such as phytogenics and certain prebiotics have become popular.
“The dry form segment dominates the market with 73.64% of total market share in terms of value in 2022.”
Dry animal intestinal health products are preferred by feed manufacturers as they are relatively cheaper than their liquid counterparts. Also, it is easier to mix the powder form of different additives. The dry form has a higher shelf life and is easier to transport. All this makes it a preferred alternative among feed manufacturers and feeders.
Break-up of Primaries:
1. Cargill, Incorporated (US)
2. Koninklijke DSM N.V. (Netherlands)
3. Archer Daniels Midland Company (US)
4. DuPont de Nemours, Inc. (US)
5. Evonik Industries (Germany)
6. Novozymes (Denmark)
7. Nutreco (Netherlands)
8. Chr. Hansen Holdings (Denmark)
9. Bluestar Adisseo Pvt Ltd. (China).
10. Alltech (US)
11. Evonik Industries (Germany)
12. Lallemand, Inc. (Canada)
13. Biorigin (Brazil)
14. Land and O’Lakes, Inc. (US)
15. Lesaffre (France)
16. Calpis Co., Ltd. (Japan)
17. AB Vista (England)
18. Pure Cultures (US)
19. Dr. Eckel Animal Nutrition GmbH & Co. KG (Germany)
20. Unique Biotech (India)
Research Coverage:
The report segments the Animal intestinal health market on the basis of Additive, Function, Source, Livestock, Form, and region. In terms of insights, this report has focused on various levels of analyses—the competitive landscape, end-use analysis, and company profiles, which together comprise and discuss views on the emerging & high-growth segments of the Animal intestinal health market, high-growth regions, countries, government initiatives, drivers, restraints, opportunities, and challenges.
Reasons to buy this report:
“Europe is the second fastest growing region, projected to witness the growth of 7.62% during the forecast period in terms of volume.”
The European feed industry is one of the largest markets for feed production at a global level. European feed producers are using various feed additives based on probiotics, prebiotics, phytogenics, and immunostimulants to cater to the increase in demand for high-quality feed products for enhanced performance of livestock. Various feed producers in the region are witnessing a shift in their focus on the inclusion of prebiotics, such as mannan oligosaccharides and fructooligosaccharides, which improves performance in livestock. The European feed producers prefer using phytogenics, such as essential oils, as an alternative to feed-grade antibiotics used in pork feed production. These phytogenics act as a key feed additive, help increase feed intake and improve gut functions in the livestock.
“The microbial segment accounted for a larger market share during the forecast period”
The microbial segment accounted for a larger market share during the forecast period due to the increase in the availability of feed additives manufactured by using microorganisms. Probiotics help in weight gain, improve the digestibility of feed products, and enhance the overall gut microflora in livestock species, such as swine, ruminants, and poultry. However, with the increase in awareness about the various alternatives to microbial sources, plant-based sources of intestinal health, such as phytogenics and certain prebiotics have become popular.
“The dry form segment dominates the market with 73.64% of total market share in terms of value in 2022.”
Dry animal intestinal health products are preferred by feed manufacturers as they are relatively cheaper than their liquid counterparts. Also, it is easier to mix the powder form of different additives. The dry form has a higher shelf life and is easier to transport. All this makes it a preferred alternative among feed manufacturers and feeders.
Break-up of Primaries:
- By Company Type: Tier 1 – 60.0%, Tier 2- 25.0%, Tier 3 – 15.0%
- By Designation: Managers – 45.0%, CXOs – 35.0%, and Executives- 20.0%
- By Region: Europe - 45%, North America - 10%, Asia Pacific – 25%, South America-5%, RoW – 15%
1. Cargill, Incorporated (US)
2. Koninklijke DSM N.V. (Netherlands)
3. Archer Daniels Midland Company (US)
4. DuPont de Nemours, Inc. (US)
5. Evonik Industries (Germany)
6. Novozymes (Denmark)
7. Nutreco (Netherlands)
8. Chr. Hansen Holdings (Denmark)
9. Bluestar Adisseo Pvt Ltd. (China).
10. Alltech (US)
11. Evonik Industries (Germany)
12. Lallemand, Inc. (Canada)
13. Biorigin (Brazil)
14. Land and O’Lakes, Inc. (US)
15. Lesaffre (France)
16. Calpis Co., Ltd. (Japan)
17. AB Vista (England)
18. Pure Cultures (US)
19. Dr. Eckel Animal Nutrition GmbH & Co. KG (Germany)
20. Unique Biotech (India)
Research Coverage:
The report segments the Animal intestinal health market on the basis of Additive, Function, Source, Livestock, Form, and region. In terms of insights, this report has focused on various levels of analyses—the competitive landscape, end-use analysis, and company profiles, which together comprise and discuss views on the emerging & high-growth segments of the Animal intestinal health market, high-growth regions, countries, government initiatives, drivers, restraints, opportunities, and challenges.
Reasons to buy this report:
- To get a comprehensive overview of the Animal Intestinal Health market
- To gain wide-ranging information about the top players in this industry, their product portfolios, and key strategies adopted by them
- To gain insights about the major countries/regions in which the Animal Intestinal Health market market is flourishing
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
FIGURE 1 MARKET SEGMENTATION
1.3.1 REGIONS COVERED
1.4 YEARS CONSIDERED
1.5 CURRENCY CONSIDERED
TABLE 1 USD EXCHANGE RATES CONSIDERED, 2019-2021
1.6 UNIT CONSIDERED
1.7 STAKEHOLDERS
1.8 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 2 ANIMAL INTESTINAL HEALTH MARKET: RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Breakdown of primary interviews
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY VALUE CHAIN, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 4 ANIMAL INTESTINAL HEALTH MARKET SIZE ESTIMATION: SUPPLY SIDE (1/2)
FIGURE 5 ANIMAL INTESTINAL HEALTH MARKET SIZE ESTIMATION: SUPPLY SIDE (2/2)
FIGURE 6 ANIMAL INTESTINAL HEALTH MARKET SIZE ESTIMATION: DEMAND SIDE
2.2.1 BOTTOM-UP APPROACH
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 9 DATA TRIANGULATION METHODOLOGY
2.4 RESEARCH ASSUMPTIONS AND LIMITATIONS
2.4.1 ASSUMPTIONS
2.4.2 LIMITATIONS
3 EXECUTIVE SUMMARY
FIGURE 10 PROBIOTICS SEGMENT EXPECTED TO ACCOUNT FOR LARGEST MARKET SIZE BY 2027
FIGURE 11 POULTRY SEGMENT EXPECTED TO ACCOUNT FOR LARGEST MARKET SIZE BY 2027
FIGURE 12 DRY FORM SEGMENT EXPECTED TO ACCOUNT FOR LARGER MARKET SHARE BY 2022
FIGURE 13 MICROBIAL SEGMENT EXPECTED TO ACCOUNT FOR LARGER MARKET SIZE BY 2027
FIGURE 14 ASIA PACIFIC EXPECTED TO ACCOUNT FOR LARGEST MARKET SHARE IN 2022
4 PREMIUM INSIGHTS
4.1 OPPORTUNITIES IN ANIMAL INTESTINAL HEALTH MARKET
FIGURE 15 INCREASE IN DEMAND FOR FEED AND FEED ADDITIVES DRIVING GROWTH OF ANIMAL INTESTINAL HEALTH MARKET
4.2 ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE
FIGURE 16 PROBIOTICS SEGMENT EXPECTED TO ACCOUNT FOR LARGEST MARKET SHARE IN 2022
4.3 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK AND KEY COUNTRIES
FIGURE 17 CHINA AND POULTRY SEGMENT EXPECTED TO ACCOUNT FOR SIGNIFICANT MARKET SHARE IN ASIA PACIFIC MARKET IN 2022
4.4 ANIMAL INTESTINAL HEALTH MARKET, BY FORM AND REGION
FIGURE 18 DRY SEGMENT EXPECTED TO ACCOUNT FOR LARGER MARKET SHARE IN 2022
4.5 ANIMAL INTESTINAL HEALTH MARKET, BY MAJOR REGIONAL SUBMARKETS
FIGURE 19 CHINA EXPECTED TO ACCOUNT FOR LARGEST MARKET SHARE IN 2022
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 20 ANIMAL INTESTINAL HEALTH MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increased production of compound feed
FIGURE 21 GLOBAL COMPOUND FEED PRODUCTION, 2012–2021 (MILLION METRIC TONS)
FIGURE 22 COMPOUND FEED PRODUCTION, BY TOP 7 COUNTRIES, 2016–2020 (MILLION METRIC TONS)
5.2.1.2 Rising demand for animal protein
TABLE 2 PER CAPITA CONSUMPTION OF LIVESTOCK PRODUCTS, BY REGION
5.2.1.3 Intestinal disorders among livestock
5.2.2 RESTRAINTS
5.2.2.1 Stringent regulations for use of feed additives
5.2.3 OPPORTUNITIES
5.2.3.1 Innovations and technological advancements in feed industry
5.2.3.2 Increased awareness about feed and food safety
5.2.4 CHALLENGES
5.2.4.1 High cost of feed additives
5.2.4.1.1 R&D costs associated with development of probiotics
5.2.4.1.2 High cost of active ingredients used in development of phytogenic feed additives
6 INDUSTRY TRENDS
6.1 INTRODUCTION
6.2 TRENDS IMPACTING CUSTOMERS’ BUSINESS
FIGURE 23 TRENDS IMPACTING ANIMAL INTESTINAL HEALTH MARKET
6.3 VALUE CHAIN
FIGURE 24 VALUE CHAIN ANALYSIS
6.4 TRADE ANALYSIS
FIGURE 25 EXPORT OF LIVESTOCK SPECIES, 2016–2021 (USD MILLION)
6.5 TECHNOLOGY ANALYSIS
6.6 PATENT ANALYSIS
TABLE 3 KEY PATENTS PERTAINING TO ANIMAL INTESTINAL HEALTH, 2019–2022
6.7 ECOSYSTEM MAP
6.7.1 ANIMAL INTESTINAL HEALTH MARKET: ECOSYSTEM MAP
FIGURE 26 FEED AND ANIMAL NUTRITION: ECOSYSTEM MAP
6.8 PORTER’S FIVE FORCES ANALYSIS
TABLE 4 PORTER’S FIVE FORCES ANALYSIS
6.8.1 THREAT OF NEW ENTRANTS
6.8.2 THREAT OF SUBSTITUTES
6.8.3 BARGAINING POWER OF SUPPLIERS
6.8.4 BARGAINING POWER OF BUYERS
6.8.5 INTENSITY OF COMPETITIVE RIVALRY
6.9 CASE STUDIES
6.9.1 REGULATIONS ON ANTIBIOTICS LEADING TO A SHIFT TOWARD PROBIOTICS
6.10 PRICING ANALYSIS
6.10.1 ANIMAL INTESTINAL HEALTH MARKET: AVERAGE SELLING PRICE TREND ANALYSIS
TABLE 5 AVERAGE SELLING PRICE, BY ADDITIVE, 2019–2027 (USD/KG)
6.11 REGULATORY FRAMEWORK
6.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
6.11.2 CODEX ALIMENTARIUS COMMISSION (CAC)
6.11.2.1 North America
6.11.2.2 Europe
6.11.2.3 Asia Pacific
6.12 KEY STAKEHOLDERS AND BUYING CRITERIA
6.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING ANIMAL INTESTINAL HEALTH PRODUCTS
TABLE 6 INFLUENCE OF STAKEHOLDERS ON TOP THREE PRODUCT TYPES
6.12.2 BUYING CRITERIA
FIGURE 28 KEY BUYING CRITERIA FOR ADDITIVES
TABLE 7 KEY BUYING CRITERIA FOR ADDITIVES
6.13 KEY CONFERENCES AND EVENTS, 2022–2023
TABLE 8 ANIMAL INTESTINAL HEALTH MARKET: DETAILED LIST OF CONFERENCES & EVENTS, BY REGION, 2022–2023
7 ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE
7.1 INTRODUCTION
FIGURE 29 PROBIOTICS SEGMENT EXPECTED TO DOMINATE ANIMAL INTESTINAL HEALTH MARKET BY 2027
TABLE 9 ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (USD MILLION)
TABLE 10 ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (KT)
7.2 PROBIOTICS
7.2.1 PROBIOTIC MICROORGANISMS OFFER HEALTH BENEFITS
TABLE 11 PROBIOTICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 12 PROBIOTICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT)
7.3 PREBIOTICS
7.3.1 PREBIOTICS INDUCE GROWTH OF BENEFICIAL GUT BACTERIA
7.3.1.1 Oligosaccharides
7.3.1.2 Inulin
7.3.1.3 Other additives
TABLE 13 PREBIOTICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 14 PREBIOTICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT)
7.4 PHYTOGENICS
7.4.1 PHYTOGENIC FEED ADDITIVES OFFER MORE THAN FLAVORING PROPERTIES
7.4.1.1 Essential oils
7.4.1.2 Flavonoids
7.4.1.3 Saponins
7.4.1.4 Oleoresins
7.4.1.5 Other additives
TABLE 15 PHYTOGENICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 16 PHYTOGENICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT)
7.5 IMMUNOSTIMULANTS
7.5.1 IMMUNOSTIMULANTS IMPROVE IMMUNITY AND REDUCE STRESS AND DISEASES IN AQUACULTURE
TABLE 17 IMMUNOSTIMULANTS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 18 IMMUNOSTIMULANTS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT)
8 ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK
8.1 INTRODUCTION
FIGURE 30 POULTRY SEGMENT EXPECTED TO DOMINATE ANIMAL INTESTINAL HEALTH MARKET DURING FORECAST PERIOD
TABLE 19 ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
TABLE 20 ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (KT)
8.2 POULTRY
8.2.1 FEED ADDITIVES ENHANCE POULTRY PERFORMANCE
TABLE 21 POULTRY: ANIMAL INTESTINAL HEALTH MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 22 POULTRY: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 23 POULTRY: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT)
8.2.1.1 Broilers
8.2.1.2 Layers
8.2.1.3 Turkey
8.2.1.4 Other poultry species
8.3 SWINE
8.3.1 RISE IN PORK TRADE AND CONCERNS OVER MEAT SAFETY
TABLE 24 PROBIOTIC MICROORGANISMS USED IN SWINE FEED
TABLE 25 SWINE: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 26 SWINE: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT)
8.4 RUMINANTS
8.4.1 FEED ADDITIVES BOOST PRODUCTION EFFICIENCY IN RUMINANTS
TABLE 27 RUMINANTS: ANIMAL INTESTINAL HEALTH MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 28 RUMINANTS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 29 RUMINANTS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT)
8.4.1.1 Dairy cattle
8.4.1.2 Beef cattle
8.4.1.3 Calves
8.4.1.4 Other ruminant species
8.5 AQUACULTURE
8.5.1 FEED ADDITIVES IMPROVE FEED QUALITY AND ENHANCE AQUACULTURE PERFORMANCE
TABLE 30 AQUACULTURE: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 31 AQUACULTURE: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT)
8.6 OTHER LIVESTOCK
8.6.1 PHYTOGENIC-BASED ANIMAL INTESTINAL PRODUCTS IMPROVE DIGESTIBILITY IN PETS
TABLE 32 OTHER LIVESTOCK: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 33 OTHER LIVESTOCK: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT)
9 ANIMAL INTESTINAL HEALTH MARKET, BY FORM
9.1 INTRODUCTION
FIGURE 31 DRY SEGMENT EXPECTED TO DOMINATE ANIMAL INTESTINAL HEALTH MARKET DURING FORECAST PERIOD
TABLE 34 ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (USD MILLION)
TABLE 35 ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (KT)
9.2 DRY
9.2.1 EASE OF STORAGE AND TRANSPORTATION
TABLE 36 DRY FORM: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 37 DRY FORM: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT)
9.3 LIQUID
9.3.1 LIQUID SUPPLEMENTS PROVIDE UNIFORM TEXTURE TO FINAL PRODUCTS
TABLE 38 LIQUID FORM: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 39 LIQUID FORM: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT)
10 ANIMAL INTESTINAL HEALTH MARKET, BY FUNCTION
10.1 METABOLISM
10.1.1 ADDITIVES IMPROVE SURVIVAL AND IMPLANTATION OF LIVE MICROBIAL DIETARY SUPPLEMENTS IN GI TRACT
10.2 WEIGHT GAIN
10.2.1 FEED ADDITIVES IMPROVE PRODUCTION AND PERFORMANCE OF RUMINANTS
10.3 NUTRIENT DIGESTION
10.3.1 FEED ADDITIVES IMPROVE DIGESTIBILITY OF NUTRIENTS
10.4 DISEASE PREVENTION
10.4.1 USE OF FEED ADDITIVES PREVENTS DISEASES IN ANIMALS AND IMPROVES HEALTH
10.5 BONE AND JOINT HEALTH
10.5.1 PREBIOTICS BETTER CALCIUM METABOLISM AND BONE HEALTH
11 ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE
11.1 INTRODUCTION
FIGURE 32 MICROBIAL SEGMENT EXPECTED TO DOMINATE ANIMAL INTESTINAL HEALTH MARKET DURING FORECAST PERIOD
TABLE 40 ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (USD MILLION)
TABLE 41 ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (KT)
11.2 MICROBIAL
11.2.1 PROBIOTICS PREPARED USING BACILLUS SUBTILIS AND STREPTOCOCCI IMPROVE EFFICIENCY IN POULTRY AND SWINE
TABLE 42 MICROBIAL: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 43 MICROBIAL: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT)
11.3 PLANT-BASED
11.3.1 PLANT-BASED SUBSTANCES IMPROVE NUTRIENT DIGESTIBILITY IN ANIMALS
TABLE 44 PLANT-BASED: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 45 PLANT-BASED: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT)
12 ANIMAL INTESTINAL HEALTH MARKET, BY REGION
12.1 INTRODUCTION
FIGURE 33 INDIA EXPECTED TO WITNESS HIGH GROWTH IN ANIMAL INTESTINAL HEALTH MARKET BETWEEN 2022 AND 2027
TABLE 46 ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 47 ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027(KT)
12.2 NORTH AMERICA
FIGURE 34 NORTH AMERICA: MARKET SNAPSHOT
TABLE 48 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2019–2027 (USD MILLION)
TABLE 49 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (USD MILLION)
TABLE 50 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (KT)
TABLE 51 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
TABLE 52 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (KT)
TABLE 53 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (USD MILLION)
TABLE 54 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (KT)
TABLE 55 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (USD MILLION)
TABLE 56 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (KT)
12.2.1 US
12.2.1.1 Rise in consumption of poultry products
TABLE 57 US: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
12.2.2 CANADA
12.2.2.1 Food safety concerns and government regulations
TABLE 58 CANADA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
12.2.3 MEXICO
12.2.3.1 Rise in import of high-quality meat products
TABLE 59 MEXICO: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
12.3 EUROPE
TABLE 60 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2019–2027 (USD MILLION)
TABLE 61 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (USD MILLION)
TABLE 62 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (KT)
TABLE 63 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
TABLE 64 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (KT)
TABLE 65 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (USD MILLION)
TABLE 66 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (KT)
TABLE 67 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (USD MILLION)
TABLE 68 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (KT)
12.3.1 SPAIN
12.3.1.1 Increased demand for meat and dairy products
TABLE 69 SPAIN: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
12.3.2 GERMANY
12.3.2.1 Focus on offering high-quality meat products
TABLE 70 GERMANY: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
12.3.3 FRANCE
12.3.3.1 Rising instances of disease outbreaks
TABLE 71 FRANCE: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
12.3.4 ITALY
12.3.4.1 Need for alternative growth promoters encourage use of probiotics
TABLE 72 ITALY: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
12.3.5 UK
12.3.5.1 Intensive farming results in high use of premium quality nutrients in animal intestinal health products
TABLE 73 UK: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
12.3.6 REST OF EUROPE
12.3.6.1 Need for alternatives to antibiotic growth promoters encourage demand for phytogenics
TABLE 74 REST OF EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
12.4 ASIA PACIFIC
FIGURE 35 ASIA PACIFIC: REGIONAL SNAPSHOT
TABLE 75 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2019–2027 (USD MILLION)
TABLE 76 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (USD MILLION)
TABLE 77 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (KT)
TABLE 78 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
TABLE 79 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (KT)
TABLE 80 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (USD MILLION)
TABLE 81 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (KT)
TABLE 82 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (USD MILLION)
TABLE 83 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (KT)
12.4.1 CHINA
12.4.1.1 High consumption of meat
TABLE 84 CHINA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
12.4.2 JAPAN
12.4.2.1 Preference for high-quality feed products
TABLE 85 JAPAN: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
12.4.3 INDIA
12.4.3.1 Growing demand for high-quality poultry products
TABLE 86 INDIA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
12.4.4 SOUTH KOREA
12.4.4.1 Increase in consumption of meat products
TABLE 87 SOUTH KOREA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
12.4.5 AUSTRALIA & NEW ZEALAND
12.4.5.1 High consumption of meat products
TABLE 88 AUSTRALIA & NEW ZEALAND: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
12.4.6 REST OF ASIA PACIFIC
12.4.6.1 Commercialization of livestock products
TABLE 89 REST OF ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
12.5 SOUTH AMERICA
TABLE 90 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2019–2027 (USD MILLION)
TABLE 91 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (USD MILLION)
TABLE 92 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (KT)
TABLE 93 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
TABLE 94 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (KT)
TABLE 95 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (USD MILLION)
TABLE 96 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (KT)
TABLE 97 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (USD MILLION)
TABLE 98 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (KT)
12.5.1 BRAZIL
12.5.1.1 High demand for meat products due to high purchasing power of people
TABLE 99 BRAZIL: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
12.5.2 ARGENTINA
12.5.2.1 Growth in animal husbandry sector
TABLE 100 ARGENTINA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
12.5.3 REST OF SOUTH AMERICA
12.5.3.1 Increased awareness among farmers about importance of feed supplements
TABLE 101 REST OF SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
12.6 REST OF THE WORLD
TABLE 102 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2019–2027 (USD MILLION)
TABLE 103 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (USD MILLION)
TABLE 104 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (KT)
TABLE 105 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
TABLE 106 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (KT)
TABLE 107 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (USD MILLION)
TABLE 108 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (KT)
TABLE 109 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (USD MILLION)
TABLE 110 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (KT)
12.6.1 MIDDLE EAST
12.6.1.1 High demand for animal-based protein products
TABLE 111 MIDDLE EAST: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
12.6.2 AFRICA
12.6.2.1 Improvement in livestock health
TABLE 112 AFRICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
13 COMPETITIVE LANDSCAPE
13.1 OVERVIEW
13.2 MARKET EVALUATION FRAMEWORK
FIGURE 36 MARKET EVALUATION FRAMEWORK, 2019–2022
13.3 MARKET SHARE ANALYSIS
TABLE 113 ANIMAL INTESTINAL HEALTH MARKET SHARE ANALYSIS, 2021
13.4 REVENUE ANALYSIS FOR KEY COMPANIES, 2019-2021 (USD BILLION)
FIGURE 37 REVENUE ANALYSIS OF KEY COMPANIES, 2019-2021 (USD BILLION)
13.5 COMPANY EVALUATION QUADRANT
13.5.1 STARS
13.5.2 EMERGING LEADERS
13.5.3 PERVASIVE PLAYERS
13.5.4 PARTICIPANTS
FIGURE 38 ANIMAL INTESTINAL HEALTH MARKET: COMPANY EVALUATION QUADRANT FOR KEY PLAYERS, 2021
13.6 STARTUP EVALUATION QUADRANT
13.6.1 PROGRESSIVE COMPANIES
13.6.2 STARTING BLOCKS
13.6.3 RESPONSIVE COMPANIES
13.6.4 DYNAMIC COMPANIES
FIGURE 39 ANIMAL INTESTINAL HEALTH MARKET: COMPANY EVALUATION QUADRANT FOR SMES/STARTUPS, 2021
13.7 PRODUCT FOOTPRINT (KEY PLAYERS)
TABLE 114 COMPANY FOOTPRINT, BY LIVESTOCK
TABLE 115 COMPANY FOOTPRINT, BY ADDITIVE
TABLE 116 COMPANY FOOTPRINT, BY REGION
TABLE 117 OVERALL COMPANY FOOTPRINT
13.7.1 COMPETITIVE BENCHMARKING OF KEY PLAYERS
TABLE 118 ANIMAL INTESTINAL HEALTH MARKET: DETAILED LIST OF KEY PLAYERS
13.7.2 COMPETITIVE BENCHMARKING OF SMES/OTHER PLAYERS
TABLE 119 ANIMAL INTESTINAL HEALTH MARKET: DETAILED LIST OF SMES/OTHER PLAYERS
13.8 PRODUCT LAUNCHES, DEALS, AND OTHER DEVELOPMENTS
13.8.1 NEW PRODUCT LAUNCHES
TABLE 120 ANIMAL INTESTINAL HEALTH MARKET: NEW PRODUCT LAUNCHES, 2019-2021
13.8.2 OTHER DEVELOPMENTS
TABLE 121 ANIMAL INTESTINAL HEALTH MARKET: OTHER DEVELOPMENTS, 2019-2020
13.8.3 DEALS
TABLE 122 ANIMAL INTESTINAL HEALTH MARKET: DEALS, 2020-2021
14 COMPANY PROFILES
(Business overview, Products offered, Recent Developments, MNM view)*
14.1 KEY PLAYERS
14.1.1 ADM
TABLE 123 ADM: BUSINESS OVERVIEW
FIGURE 40 ADM: COMPANY SNAPSHOT
TABLE 124 ADM: PRODUCTS OFFERED
TABLE 125 ADM: OTHERS, 2021
TABLE 126 ADM: PRODUCT LAUNCHES, 2020
14.1.2 KONINKLIJKE DSM N.V.
TABLE 127 KONINKLIJKE DSM N.V.: BUSINESS OVERVIEW
FIGURE 41 KONINKLIJKE DSM N.V.: COMPANY SNAPSHOT
TABLE 128 KONINKLIJKE DSM N.V.: PRODUCTS OFFERED
TABLE 129 KONINKLIJKE DSM N.V.: DEALS, 2020
14.1.3 DUPONT NUTRITION & BIOSCIENCES (DANISCO ANIMAL NUTRITION)
TABLE 130 DUPONT NUTRITION & BIOSCIENCES: BUSINESS OVERVIEW
FIGURE 42 DUPONT NUTRITION & BIOSCIENCES: COMPANY SNAPSHOT
TABLE 131 DUPONT NUTRITION & BIOSCIENCES: PRODUCTS OFFERED
TABLE 132 DUPONT NUTRITION & BIOSCIENCES: DEALS, 2019-2021
TABLE 133 DUPONT NUTRITION & BIOSCIENCES: PRODUCT LAUNCHES, 2019
TABLE 134 DUPONT NUTRITION & BIOSCIENCES: OTHERS, 2020
14.1.4 CARGILL INCORPORATED
TABLE 135 CARGILL INCORPORATED: BUSINESS OVERVIEW
FIGURE 43 CARGILL INC.: COMPANY SNAPSHOT
TABLE 136 CARGILL INCORPORATED: PRODUCTS OFFERED
TABLE 137 CARGILL INCORPORATED: DEALS, 2020
TABLE 138 CARGILL INCORPORATED: OTHERS, 2022
14.1.5 NOVOZYMES
TABLE 139 NOVOZYMES: BUSINESS OVERVIEW
FIGURE 44 NOVOZYMES: COMPANY SNAPSHOT
TABLE 140 NOVOZYMES: PRODUCTS OFFERED
TABLE 141 NOVOZYMES: DEALS, 2020
14.1.6 KEMIN INDUSTRIES INC.
TABLE 142 KEMIN INDUSTRIES INC.: BUSINESS OVERVIEW
TABLE 143 KEMIN INDUSTRIES INC.: PRODUCTS OFFERED
TABLE 144 KEMIN INDUSTRIES: PRODUCT LAUNCHES, 2020
14.1.7 NUTRECO
TABLE 145 NUTRECO: BUSINESS OVERVIEW
FIGURE 45 NUTRECO: COMPANY SNAPSHOT
TABLE 146 NUTRECO: PRODUCTS OFFERED
TABLE 147 NUTRECO: DEALS 2019-2020
14.1.8 CHR. HANSEN HOLDING A/S
TABLE 148 CHR. HANSEN HOLDING A/S: BUSINESS OVERVIEW
FIGURE 46 CHR. HANSEN HOLDING A/S: COMPANY SNAPSHOT
TABLE 149 CHR. HANSEN HOLDING A/S: PRODUCTS OFFERED
TABLE 150 CHR. HANSEN HOLDING A/S: PRODUCT LAUNCHES, 2019-2021
TABLE 151 CHR. HANSEN HOLDING A/S: DEALS, 2020
14.1.9 BLUESTAR ADISSEO CO. LTD.
TABLE 152 BLUESTAR ADISSEO: BUSINESS OVERVIEW
FIGURE 47 BLUESTAR ADISSEO CO. LTD.: COMPANY SNAPSHOT
TABLE 153 BLUESTAR ADISSEO CO. LTD.: PRODUCTS OFFERED
TABLE 154 BLUESTAR ADISSEO CO. LTD.: DEALS, 2020
14.1.10 ALLTECH
TABLE 155 ALLTECH: BUSINESS OVERVIEW
TABLE 156 ALLTECH: PRODUCTS OFFERED
14.1.11 EVONIK INDUSTRIES
TABLE 157 EVONIK INDUSTRIES: BUSINESS OVERVIEW
FIGURE 48 EVONIK INDUSTRIES: COMPANY SNAPSHOT
TABLE 158 EVONIK INDUSTRIES: PRODUCTS OFFERED
TABLE 159 EVONIK INDUSTRIES: PRODUCT LAUNCHES, 2020
14.1.12 LALLEMAND INC.
TABLE 160 LALLEMAND INC.: BUSINESS OVERVIEW
TABLE 161 LALLEMAND INC.: PRODUCTS OFFERED
TABLE 162 LALLEMAND INC.: OTHER DEVELOPMENTS, 2019-2020
14.1.13 BIORIGIN
TABLE 163 BIORIGIN: BUSINESS OVERVIEW
TABLE 164 BIORIGIN: PRODUCTS OFFERED
TABLE 165 BIORIGIN: DEALS, 2019
14.1.14 LAND O’LAKES
TABLE 166 LAND O’LAKES: BUSINESS OVERVIEW
FIGURE 49 LAND O’LAKES: COMPANY SNAPSHOT
TABLE 167 LAND O’LAKES: PRODUCTS OFFERED
TABLE 168 LAND O’LAKES: OTHERS, 2019
TABLE 169 LAND O’LAKES: DEALS, 2019
14.1.15 LESAFFRE
TABLE 170 LESAFFRE: BUSINESS OVERVIEW
TABLE 171 LESAFFRE: PRODUCTS OFFERED
TABLE 172 LESAFFRE: OTHER DEVELOPMENTS, 2019-2020
TABLE 173 LESAFFRE: PRODUCT LAUNCHES, 2019
14.1.16 CALPIS CO LTD
TABLE 174 CALPIS CO LTD.: BUSINESS OVERVIEW
14.1.17 AB VISTA
14.1.18 PURE CULTURES
14.1.19 DR. ECKEL ANIMAL NUTRITION GMBH & CO. KG
14.1.20 UNIQUE BIOTECH
*Details on Business overview, Products offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
15 ADJACENT AND RELATED MARKETS
15.1 INTRODUCTION
TABLE 175 ADJACENT MARKETS TO ANIMAL INTESTINAL HEALTH
15.2 LIMITATIONS
15.3 PHYTOGENIC FEED ADDITIVES MARKET
15.3.1 MARKET DEFINITION
15.3.2 MARKET OVERVIEW
TABLE 176 PHYTOGENIC FEED ADDITIVES MARKET, BY SOURCE, 2016–2019 (USD MILLION)
TABLE 177 PHYTOGENIC FEED ADDITIVES MARKET, BY SOURCE, 2020–2025 (USD MILLION)
15.4 PROBIOTICS IN ANIMAL FEED MARKET
15.4.1 MARKET DEFINITION
TABLE 178 PROBIOTICS IN ANIMAL FEED MARKET, BY LIVESTOCK, 2017–2020 (USD MILLION)
TABLE 179 PROBIOTICS IN ANIMAL FEED MARKET, BY LIVESTOCK, 2021–2026 (USD MILLION)
16 APPENDIX
16.1 DISCUSSION GUIDE
16.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.3 AVAILABLE CUSTOMIZATION
16.4 RELATED REPORTS
16.5 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
FIGURE 1 MARKET SEGMENTATION
1.3.1 REGIONS COVERED
1.4 YEARS CONSIDERED
1.5 CURRENCY CONSIDERED
TABLE 1 USD EXCHANGE RATES CONSIDERED, 2019-2021
1.6 UNIT CONSIDERED
1.7 STAKEHOLDERS
1.8 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 2 ANIMAL INTESTINAL HEALTH MARKET: RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Breakdown of primary interviews
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY VALUE CHAIN, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 4 ANIMAL INTESTINAL HEALTH MARKET SIZE ESTIMATION: SUPPLY SIDE (1/2)
FIGURE 5 ANIMAL INTESTINAL HEALTH MARKET SIZE ESTIMATION: SUPPLY SIDE (2/2)
FIGURE 6 ANIMAL INTESTINAL HEALTH MARKET SIZE ESTIMATION: DEMAND SIDE
2.2.1 BOTTOM-UP APPROACH
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 9 DATA TRIANGULATION METHODOLOGY
2.4 RESEARCH ASSUMPTIONS AND LIMITATIONS
2.4.1 ASSUMPTIONS
2.4.2 LIMITATIONS
3 EXECUTIVE SUMMARY
FIGURE 10 PROBIOTICS SEGMENT EXPECTED TO ACCOUNT FOR LARGEST MARKET SIZE BY 2027
FIGURE 11 POULTRY SEGMENT EXPECTED TO ACCOUNT FOR LARGEST MARKET SIZE BY 2027
FIGURE 12 DRY FORM SEGMENT EXPECTED TO ACCOUNT FOR LARGER MARKET SHARE BY 2022
FIGURE 13 MICROBIAL SEGMENT EXPECTED TO ACCOUNT FOR LARGER MARKET SIZE BY 2027
FIGURE 14 ASIA PACIFIC EXPECTED TO ACCOUNT FOR LARGEST MARKET SHARE IN 2022
4 PREMIUM INSIGHTS
4.1 OPPORTUNITIES IN ANIMAL INTESTINAL HEALTH MARKET
FIGURE 15 INCREASE IN DEMAND FOR FEED AND FEED ADDITIVES DRIVING GROWTH OF ANIMAL INTESTINAL HEALTH MARKET
4.2 ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE
FIGURE 16 PROBIOTICS SEGMENT EXPECTED TO ACCOUNT FOR LARGEST MARKET SHARE IN 2022
4.3 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK AND KEY COUNTRIES
FIGURE 17 CHINA AND POULTRY SEGMENT EXPECTED TO ACCOUNT FOR SIGNIFICANT MARKET SHARE IN ASIA PACIFIC MARKET IN 2022
4.4 ANIMAL INTESTINAL HEALTH MARKET, BY FORM AND REGION
FIGURE 18 DRY SEGMENT EXPECTED TO ACCOUNT FOR LARGER MARKET SHARE IN 2022
4.5 ANIMAL INTESTINAL HEALTH MARKET, BY MAJOR REGIONAL SUBMARKETS
FIGURE 19 CHINA EXPECTED TO ACCOUNT FOR LARGEST MARKET SHARE IN 2022
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 20 ANIMAL INTESTINAL HEALTH MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increased production of compound feed
FIGURE 21 GLOBAL COMPOUND FEED PRODUCTION, 2012–2021 (MILLION METRIC TONS)
FIGURE 22 COMPOUND FEED PRODUCTION, BY TOP 7 COUNTRIES, 2016–2020 (MILLION METRIC TONS)
5.2.1.2 Rising demand for animal protein
TABLE 2 PER CAPITA CONSUMPTION OF LIVESTOCK PRODUCTS, BY REGION
5.2.1.3 Intestinal disorders among livestock
5.2.2 RESTRAINTS
5.2.2.1 Stringent regulations for use of feed additives
5.2.3 OPPORTUNITIES
5.2.3.1 Innovations and technological advancements in feed industry
5.2.3.2 Increased awareness about feed and food safety
5.2.4 CHALLENGES
5.2.4.1 High cost of feed additives
5.2.4.1.1 R&D costs associated with development of probiotics
5.2.4.1.2 High cost of active ingredients used in development of phytogenic feed additives
6 INDUSTRY TRENDS
6.1 INTRODUCTION
6.2 TRENDS IMPACTING CUSTOMERS’ BUSINESS
FIGURE 23 TRENDS IMPACTING ANIMAL INTESTINAL HEALTH MARKET
6.3 VALUE CHAIN
FIGURE 24 VALUE CHAIN ANALYSIS
6.4 TRADE ANALYSIS
FIGURE 25 EXPORT OF LIVESTOCK SPECIES, 2016–2021 (USD MILLION)
6.5 TECHNOLOGY ANALYSIS
6.6 PATENT ANALYSIS
TABLE 3 KEY PATENTS PERTAINING TO ANIMAL INTESTINAL HEALTH, 2019–2022
6.7 ECOSYSTEM MAP
6.7.1 ANIMAL INTESTINAL HEALTH MARKET: ECOSYSTEM MAP
FIGURE 26 FEED AND ANIMAL NUTRITION: ECOSYSTEM MAP
6.8 PORTER’S FIVE FORCES ANALYSIS
TABLE 4 PORTER’S FIVE FORCES ANALYSIS
6.8.1 THREAT OF NEW ENTRANTS
6.8.2 THREAT OF SUBSTITUTES
6.8.3 BARGAINING POWER OF SUPPLIERS
6.8.4 BARGAINING POWER OF BUYERS
6.8.5 INTENSITY OF COMPETITIVE RIVALRY
6.9 CASE STUDIES
6.9.1 REGULATIONS ON ANTIBIOTICS LEADING TO A SHIFT TOWARD PROBIOTICS
6.10 PRICING ANALYSIS
6.10.1 ANIMAL INTESTINAL HEALTH MARKET: AVERAGE SELLING PRICE TREND ANALYSIS
TABLE 5 AVERAGE SELLING PRICE, BY ADDITIVE, 2019–2027 (USD/KG)
6.11 REGULATORY FRAMEWORK
6.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
6.11.2 CODEX ALIMENTARIUS COMMISSION (CAC)
6.11.2.1 North America
6.11.2.2 Europe
6.11.2.3 Asia Pacific
6.12 KEY STAKEHOLDERS AND BUYING CRITERIA
6.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING ANIMAL INTESTINAL HEALTH PRODUCTS
TABLE 6 INFLUENCE OF STAKEHOLDERS ON TOP THREE PRODUCT TYPES
6.12.2 BUYING CRITERIA
FIGURE 28 KEY BUYING CRITERIA FOR ADDITIVES
TABLE 7 KEY BUYING CRITERIA FOR ADDITIVES
6.13 KEY CONFERENCES AND EVENTS, 2022–2023
TABLE 8 ANIMAL INTESTINAL HEALTH MARKET: DETAILED LIST OF CONFERENCES & EVENTS, BY REGION, 2022–2023
7 ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE
7.1 INTRODUCTION
FIGURE 29 PROBIOTICS SEGMENT EXPECTED TO DOMINATE ANIMAL INTESTINAL HEALTH MARKET BY 2027
TABLE 9 ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (USD MILLION)
TABLE 10 ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (KT)
7.2 PROBIOTICS
7.2.1 PROBIOTIC MICROORGANISMS OFFER HEALTH BENEFITS
TABLE 11 PROBIOTICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 12 PROBIOTICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT)
7.3 PREBIOTICS
7.3.1 PREBIOTICS INDUCE GROWTH OF BENEFICIAL GUT BACTERIA
7.3.1.1 Oligosaccharides
7.3.1.2 Inulin
7.3.1.3 Other additives
TABLE 13 PREBIOTICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 14 PREBIOTICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT)
7.4 PHYTOGENICS
7.4.1 PHYTOGENIC FEED ADDITIVES OFFER MORE THAN FLAVORING PROPERTIES
7.4.1.1 Essential oils
7.4.1.2 Flavonoids
7.4.1.3 Saponins
7.4.1.4 Oleoresins
7.4.1.5 Other additives
TABLE 15 PHYTOGENICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 16 PHYTOGENICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT)
7.5 IMMUNOSTIMULANTS
7.5.1 IMMUNOSTIMULANTS IMPROVE IMMUNITY AND REDUCE STRESS AND DISEASES IN AQUACULTURE
TABLE 17 IMMUNOSTIMULANTS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 18 IMMUNOSTIMULANTS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT)
8 ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK
8.1 INTRODUCTION
FIGURE 30 POULTRY SEGMENT EXPECTED TO DOMINATE ANIMAL INTESTINAL HEALTH MARKET DURING FORECAST PERIOD
TABLE 19 ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
TABLE 20 ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (KT)
8.2 POULTRY
8.2.1 FEED ADDITIVES ENHANCE POULTRY PERFORMANCE
TABLE 21 POULTRY: ANIMAL INTESTINAL HEALTH MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 22 POULTRY: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 23 POULTRY: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT)
8.2.1.1 Broilers
8.2.1.2 Layers
8.2.1.3 Turkey
8.2.1.4 Other poultry species
8.3 SWINE
8.3.1 RISE IN PORK TRADE AND CONCERNS OVER MEAT SAFETY
TABLE 24 PROBIOTIC MICROORGANISMS USED IN SWINE FEED
TABLE 25 SWINE: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 26 SWINE: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT)
8.4 RUMINANTS
8.4.1 FEED ADDITIVES BOOST PRODUCTION EFFICIENCY IN RUMINANTS
TABLE 27 RUMINANTS: ANIMAL INTESTINAL HEALTH MARKET, BY TYPE, 2019–2027 (USD MILLION)
TABLE 28 RUMINANTS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 29 RUMINANTS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT)
8.4.1.1 Dairy cattle
8.4.1.2 Beef cattle
8.4.1.3 Calves
8.4.1.4 Other ruminant species
8.5 AQUACULTURE
8.5.1 FEED ADDITIVES IMPROVE FEED QUALITY AND ENHANCE AQUACULTURE PERFORMANCE
TABLE 30 AQUACULTURE: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 31 AQUACULTURE: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT)
8.6 OTHER LIVESTOCK
8.6.1 PHYTOGENIC-BASED ANIMAL INTESTINAL PRODUCTS IMPROVE DIGESTIBILITY IN PETS
TABLE 32 OTHER LIVESTOCK: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 33 OTHER LIVESTOCK: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT)
9 ANIMAL INTESTINAL HEALTH MARKET, BY FORM
9.1 INTRODUCTION
FIGURE 31 DRY SEGMENT EXPECTED TO DOMINATE ANIMAL INTESTINAL HEALTH MARKET DURING FORECAST PERIOD
TABLE 34 ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (USD MILLION)
TABLE 35 ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (KT)
9.2 DRY
9.2.1 EASE OF STORAGE AND TRANSPORTATION
TABLE 36 DRY FORM: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 37 DRY FORM: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT)
9.3 LIQUID
9.3.1 LIQUID SUPPLEMENTS PROVIDE UNIFORM TEXTURE TO FINAL PRODUCTS
TABLE 38 LIQUID FORM: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 39 LIQUID FORM: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT)
10 ANIMAL INTESTINAL HEALTH MARKET, BY FUNCTION
10.1 METABOLISM
10.1.1 ADDITIVES IMPROVE SURVIVAL AND IMPLANTATION OF LIVE MICROBIAL DIETARY SUPPLEMENTS IN GI TRACT
10.2 WEIGHT GAIN
10.2.1 FEED ADDITIVES IMPROVE PRODUCTION AND PERFORMANCE OF RUMINANTS
10.3 NUTRIENT DIGESTION
10.3.1 FEED ADDITIVES IMPROVE DIGESTIBILITY OF NUTRIENTS
10.4 DISEASE PREVENTION
10.4.1 USE OF FEED ADDITIVES PREVENTS DISEASES IN ANIMALS AND IMPROVES HEALTH
10.5 BONE AND JOINT HEALTH
10.5.1 PREBIOTICS BETTER CALCIUM METABOLISM AND BONE HEALTH
11 ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE
11.1 INTRODUCTION
FIGURE 32 MICROBIAL SEGMENT EXPECTED TO DOMINATE ANIMAL INTESTINAL HEALTH MARKET DURING FORECAST PERIOD
TABLE 40 ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (USD MILLION)
TABLE 41 ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (KT)
11.2 MICROBIAL
11.2.1 PROBIOTICS PREPARED USING BACILLUS SUBTILIS AND STREPTOCOCCI IMPROVE EFFICIENCY IN POULTRY AND SWINE
TABLE 42 MICROBIAL: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 43 MICROBIAL: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT)
11.3 PLANT-BASED
11.3.1 PLANT-BASED SUBSTANCES IMPROVE NUTRIENT DIGESTIBILITY IN ANIMALS
TABLE 44 PLANT-BASED: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 45 PLANT-BASED: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT)
12 ANIMAL INTESTINAL HEALTH MARKET, BY REGION
12.1 INTRODUCTION
FIGURE 33 INDIA EXPECTED TO WITNESS HIGH GROWTH IN ANIMAL INTESTINAL HEALTH MARKET BETWEEN 2022 AND 2027
TABLE 46 ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION)
TABLE 47 ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027(KT)
12.2 NORTH AMERICA
FIGURE 34 NORTH AMERICA: MARKET SNAPSHOT
TABLE 48 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2019–2027 (USD MILLION)
TABLE 49 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (USD MILLION)
TABLE 50 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (KT)
TABLE 51 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
TABLE 52 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (KT)
TABLE 53 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (USD MILLION)
TABLE 54 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (KT)
TABLE 55 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (USD MILLION)
TABLE 56 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (KT)
12.2.1 US
12.2.1.1 Rise in consumption of poultry products
TABLE 57 US: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
12.2.2 CANADA
12.2.2.1 Food safety concerns and government regulations
TABLE 58 CANADA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
12.2.3 MEXICO
12.2.3.1 Rise in import of high-quality meat products
TABLE 59 MEXICO: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
12.3 EUROPE
TABLE 60 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2019–2027 (USD MILLION)
TABLE 61 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (USD MILLION)
TABLE 62 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (KT)
TABLE 63 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
TABLE 64 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (KT)
TABLE 65 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (USD MILLION)
TABLE 66 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (KT)
TABLE 67 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (USD MILLION)
TABLE 68 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (KT)
12.3.1 SPAIN
12.3.1.1 Increased demand for meat and dairy products
TABLE 69 SPAIN: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
12.3.2 GERMANY
12.3.2.1 Focus on offering high-quality meat products
TABLE 70 GERMANY: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
12.3.3 FRANCE
12.3.3.1 Rising instances of disease outbreaks
TABLE 71 FRANCE: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
12.3.4 ITALY
12.3.4.1 Need for alternative growth promoters encourage use of probiotics
TABLE 72 ITALY: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
12.3.5 UK
12.3.5.1 Intensive farming results in high use of premium quality nutrients in animal intestinal health products
TABLE 73 UK: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
12.3.6 REST OF EUROPE
12.3.6.1 Need for alternatives to antibiotic growth promoters encourage demand for phytogenics
TABLE 74 REST OF EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
12.4 ASIA PACIFIC
FIGURE 35 ASIA PACIFIC: REGIONAL SNAPSHOT
TABLE 75 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2019–2027 (USD MILLION)
TABLE 76 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (USD MILLION)
TABLE 77 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (KT)
TABLE 78 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
TABLE 79 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (KT)
TABLE 80 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (USD MILLION)
TABLE 81 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (KT)
TABLE 82 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (USD MILLION)
TABLE 83 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (KT)
12.4.1 CHINA
12.4.1.1 High consumption of meat
TABLE 84 CHINA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
12.4.2 JAPAN
12.4.2.1 Preference for high-quality feed products
TABLE 85 JAPAN: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
12.4.3 INDIA
12.4.3.1 Growing demand for high-quality poultry products
TABLE 86 INDIA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
12.4.4 SOUTH KOREA
12.4.4.1 Increase in consumption of meat products
TABLE 87 SOUTH KOREA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
12.4.5 AUSTRALIA & NEW ZEALAND
12.4.5.1 High consumption of meat products
TABLE 88 AUSTRALIA & NEW ZEALAND: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
12.4.6 REST OF ASIA PACIFIC
12.4.6.1 Commercialization of livestock products
TABLE 89 REST OF ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
12.5 SOUTH AMERICA
TABLE 90 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2019–2027 (USD MILLION)
TABLE 91 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (USD MILLION)
TABLE 92 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (KT)
TABLE 93 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
TABLE 94 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (KT)
TABLE 95 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (USD MILLION)
TABLE 96 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (KT)
TABLE 97 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (USD MILLION)
TABLE 98 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (KT)
12.5.1 BRAZIL
12.5.1.1 High demand for meat products due to high purchasing power of people
TABLE 99 BRAZIL: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
12.5.2 ARGENTINA
12.5.2.1 Growth in animal husbandry sector
TABLE 100 ARGENTINA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
12.5.3 REST OF SOUTH AMERICA
12.5.3.1 Increased awareness among farmers about importance of feed supplements
TABLE 101 REST OF SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
12.6 REST OF THE WORLD
TABLE 102 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2019–2027 (USD MILLION)
TABLE 103 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (USD MILLION)
TABLE 104 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (KT)
TABLE 105 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
TABLE 106 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (KT)
TABLE 107 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (USD MILLION)
TABLE 108 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (KT)
TABLE 109 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (USD MILLION)
TABLE 110 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (KT)
12.6.1 MIDDLE EAST
12.6.1.1 High demand for animal-based protein products
TABLE 111 MIDDLE EAST: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
12.6.2 AFRICA
12.6.2.1 Improvement in livestock health
TABLE 112 AFRICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
13 COMPETITIVE LANDSCAPE
13.1 OVERVIEW
13.2 MARKET EVALUATION FRAMEWORK
FIGURE 36 MARKET EVALUATION FRAMEWORK, 2019–2022
13.3 MARKET SHARE ANALYSIS
TABLE 113 ANIMAL INTESTINAL HEALTH MARKET SHARE ANALYSIS, 2021
13.4 REVENUE ANALYSIS FOR KEY COMPANIES, 2019-2021 (USD BILLION)
FIGURE 37 REVENUE ANALYSIS OF KEY COMPANIES, 2019-2021 (USD BILLION)
13.5 COMPANY EVALUATION QUADRANT
13.5.1 STARS
13.5.2 EMERGING LEADERS
13.5.3 PERVASIVE PLAYERS
13.5.4 PARTICIPANTS
FIGURE 38 ANIMAL INTESTINAL HEALTH MARKET: COMPANY EVALUATION QUADRANT FOR KEY PLAYERS, 2021
13.6 STARTUP EVALUATION QUADRANT
13.6.1 PROGRESSIVE COMPANIES
13.6.2 STARTING BLOCKS
13.6.3 RESPONSIVE COMPANIES
13.6.4 DYNAMIC COMPANIES
FIGURE 39 ANIMAL INTESTINAL HEALTH MARKET: COMPANY EVALUATION QUADRANT FOR SMES/STARTUPS, 2021
13.7 PRODUCT FOOTPRINT (KEY PLAYERS)
TABLE 114 COMPANY FOOTPRINT, BY LIVESTOCK
TABLE 115 COMPANY FOOTPRINT, BY ADDITIVE
TABLE 116 COMPANY FOOTPRINT, BY REGION
TABLE 117 OVERALL COMPANY FOOTPRINT
13.7.1 COMPETITIVE BENCHMARKING OF KEY PLAYERS
TABLE 118 ANIMAL INTESTINAL HEALTH MARKET: DETAILED LIST OF KEY PLAYERS
13.7.2 COMPETITIVE BENCHMARKING OF SMES/OTHER PLAYERS
TABLE 119 ANIMAL INTESTINAL HEALTH MARKET: DETAILED LIST OF SMES/OTHER PLAYERS
13.8 PRODUCT LAUNCHES, DEALS, AND OTHER DEVELOPMENTS
13.8.1 NEW PRODUCT LAUNCHES
TABLE 120 ANIMAL INTESTINAL HEALTH MARKET: NEW PRODUCT LAUNCHES, 2019-2021
13.8.2 OTHER DEVELOPMENTS
TABLE 121 ANIMAL INTESTINAL HEALTH MARKET: OTHER DEVELOPMENTS, 2019-2020
13.8.3 DEALS
TABLE 122 ANIMAL INTESTINAL HEALTH MARKET: DEALS, 2020-2021
14 COMPANY PROFILES
(Business overview, Products offered, Recent Developments, MNM view)*
14.1 KEY PLAYERS
14.1.1 ADM
TABLE 123 ADM: BUSINESS OVERVIEW
FIGURE 40 ADM: COMPANY SNAPSHOT
TABLE 124 ADM: PRODUCTS OFFERED
TABLE 125 ADM: OTHERS, 2021
TABLE 126 ADM: PRODUCT LAUNCHES, 2020
14.1.2 KONINKLIJKE DSM N.V.
TABLE 127 KONINKLIJKE DSM N.V.: BUSINESS OVERVIEW
FIGURE 41 KONINKLIJKE DSM N.V.: COMPANY SNAPSHOT
TABLE 128 KONINKLIJKE DSM N.V.: PRODUCTS OFFERED
TABLE 129 KONINKLIJKE DSM N.V.: DEALS, 2020
14.1.3 DUPONT NUTRITION & BIOSCIENCES (DANISCO ANIMAL NUTRITION)
TABLE 130 DUPONT NUTRITION & BIOSCIENCES: BUSINESS OVERVIEW
FIGURE 42 DUPONT NUTRITION & BIOSCIENCES: COMPANY SNAPSHOT
TABLE 131 DUPONT NUTRITION & BIOSCIENCES: PRODUCTS OFFERED
TABLE 132 DUPONT NUTRITION & BIOSCIENCES: DEALS, 2019-2021
TABLE 133 DUPONT NUTRITION & BIOSCIENCES: PRODUCT LAUNCHES, 2019
TABLE 134 DUPONT NUTRITION & BIOSCIENCES: OTHERS, 2020
14.1.4 CARGILL INCORPORATED
TABLE 135 CARGILL INCORPORATED: BUSINESS OVERVIEW
FIGURE 43 CARGILL INC.: COMPANY SNAPSHOT
TABLE 136 CARGILL INCORPORATED: PRODUCTS OFFERED
TABLE 137 CARGILL INCORPORATED: DEALS, 2020
TABLE 138 CARGILL INCORPORATED: OTHERS, 2022
14.1.5 NOVOZYMES
TABLE 139 NOVOZYMES: BUSINESS OVERVIEW
FIGURE 44 NOVOZYMES: COMPANY SNAPSHOT
TABLE 140 NOVOZYMES: PRODUCTS OFFERED
TABLE 141 NOVOZYMES: DEALS, 2020
14.1.6 KEMIN INDUSTRIES INC.
TABLE 142 KEMIN INDUSTRIES INC.: BUSINESS OVERVIEW
TABLE 143 KEMIN INDUSTRIES INC.: PRODUCTS OFFERED
TABLE 144 KEMIN INDUSTRIES: PRODUCT LAUNCHES, 2020
14.1.7 NUTRECO
TABLE 145 NUTRECO: BUSINESS OVERVIEW
FIGURE 45 NUTRECO: COMPANY SNAPSHOT
TABLE 146 NUTRECO: PRODUCTS OFFERED
TABLE 147 NUTRECO: DEALS 2019-2020
14.1.8 CHR. HANSEN HOLDING A/S
TABLE 148 CHR. HANSEN HOLDING A/S: BUSINESS OVERVIEW
FIGURE 46 CHR. HANSEN HOLDING A/S: COMPANY SNAPSHOT
TABLE 149 CHR. HANSEN HOLDING A/S: PRODUCTS OFFERED
TABLE 150 CHR. HANSEN HOLDING A/S: PRODUCT LAUNCHES, 2019-2021
TABLE 151 CHR. HANSEN HOLDING A/S: DEALS, 2020
14.1.9 BLUESTAR ADISSEO CO. LTD.
TABLE 152 BLUESTAR ADISSEO: BUSINESS OVERVIEW
FIGURE 47 BLUESTAR ADISSEO CO. LTD.: COMPANY SNAPSHOT
TABLE 153 BLUESTAR ADISSEO CO. LTD.: PRODUCTS OFFERED
TABLE 154 BLUESTAR ADISSEO CO. LTD.: DEALS, 2020
14.1.10 ALLTECH
TABLE 155 ALLTECH: BUSINESS OVERVIEW
TABLE 156 ALLTECH: PRODUCTS OFFERED
14.1.11 EVONIK INDUSTRIES
TABLE 157 EVONIK INDUSTRIES: BUSINESS OVERVIEW
FIGURE 48 EVONIK INDUSTRIES: COMPANY SNAPSHOT
TABLE 158 EVONIK INDUSTRIES: PRODUCTS OFFERED
TABLE 159 EVONIK INDUSTRIES: PRODUCT LAUNCHES, 2020
14.1.12 LALLEMAND INC.
TABLE 160 LALLEMAND INC.: BUSINESS OVERVIEW
TABLE 161 LALLEMAND INC.: PRODUCTS OFFERED
TABLE 162 LALLEMAND INC.: OTHER DEVELOPMENTS, 2019-2020
14.1.13 BIORIGIN
TABLE 163 BIORIGIN: BUSINESS OVERVIEW
TABLE 164 BIORIGIN: PRODUCTS OFFERED
TABLE 165 BIORIGIN: DEALS, 2019
14.1.14 LAND O’LAKES
TABLE 166 LAND O’LAKES: BUSINESS OVERVIEW
FIGURE 49 LAND O’LAKES: COMPANY SNAPSHOT
TABLE 167 LAND O’LAKES: PRODUCTS OFFERED
TABLE 168 LAND O’LAKES: OTHERS, 2019
TABLE 169 LAND O’LAKES: DEALS, 2019
14.1.15 LESAFFRE
TABLE 170 LESAFFRE: BUSINESS OVERVIEW
TABLE 171 LESAFFRE: PRODUCTS OFFERED
TABLE 172 LESAFFRE: OTHER DEVELOPMENTS, 2019-2020
TABLE 173 LESAFFRE: PRODUCT LAUNCHES, 2019
14.1.16 CALPIS CO LTD
TABLE 174 CALPIS CO LTD.: BUSINESS OVERVIEW
14.1.17 AB VISTA
14.1.18 PURE CULTURES
14.1.19 DR. ECKEL ANIMAL NUTRITION GMBH & CO. KG
14.1.20 UNIQUE BIOTECH
*Details on Business overview, Products offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
15 ADJACENT AND RELATED MARKETS
15.1 INTRODUCTION
TABLE 175 ADJACENT MARKETS TO ANIMAL INTESTINAL HEALTH
15.2 LIMITATIONS
15.3 PHYTOGENIC FEED ADDITIVES MARKET
15.3.1 MARKET DEFINITION
15.3.2 MARKET OVERVIEW
TABLE 176 PHYTOGENIC FEED ADDITIVES MARKET, BY SOURCE, 2016–2019 (USD MILLION)
TABLE 177 PHYTOGENIC FEED ADDITIVES MARKET, BY SOURCE, 2020–2025 (USD MILLION)
15.4 PROBIOTICS IN ANIMAL FEED MARKET
15.4.1 MARKET DEFINITION
TABLE 178 PROBIOTICS IN ANIMAL FEED MARKET, BY LIVESTOCK, 2017–2020 (USD MILLION)
TABLE 179 PROBIOTICS IN ANIMAL FEED MARKET, BY LIVESTOCK, 2021–2026 (USD MILLION)
16 APPENDIX
16.1 DISCUSSION GUIDE
16.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.3 AVAILABLE CUSTOMIZATION
16.4 RELATED REPORTS
16.5 AUTHOR DETAILS
